Epidemiology of and Stroke-Preventive Strategies for Atherothromboembolic Brain Infarction in the Elderly

Acheson, 1969, Controlled trial of dipyridamole in cerebral vascular disease, Br Med J, 1, 614, 10.1136/bmj.1.5644.614 Adams, 1984, The patient with transient ischemic attacks: Is this the time for a new therapeutic approach?, Stroke, 15, 371, 10.1161/01.STR.15.2.371 1985, Persantine aspirin trial in cerebral ischemia. Part II: Endpoint results, Stroke, 16, 406, 10.1161/01.STR.16.3.406 1988, Secondary prevention of vascular disease by prolonged antiplatelet treatment, Br Med J, 296, 320, 10.1136/bmj.296.6618.320 Baker, 1961, An evaluation of anticoagulant therapy in the treatment of cerebrovascu lar disease: Report of the Veterans Administration Cooperative Study of Atherosclerosis (Neurology Section), Neurology, 11, 132, 10.1212/WNL.11.4_Part_2.132 Baker, 1962, Anticoagulant therapy in cerebral infarction: Report on cooperative study, Neurology, 12, 823, 10.1212/WNL.12.12.823 Baker, 1966, Transient ischemic attacks. A report of a study of anticoagulant therapy, Neurology, 16, 841, 10.1212/WNL.16.9.841 Balsano, 1990, Antiplatelet treatment with ticlopidine in unstable angina: A controlled multicenter clinical trial, Circulation, 82, 17, 10.1161/01.CIR.82.1.17 Becker, 1989, Heparin-induced thrombocytopenia, Stroke, 20, 1449, 10.1161/01.STR.20.11.1449 Bern, 1990, Very low doses of warfarin can prevent thrombosis in central venous catheters: A randomized prospective trial, Ann Intern Med, 112, 423, 10.7326/0003-4819-76-3-112-6-423 Biller, 1989, A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks: A pilot study, Stroke, 20, 441, 10.1161/01.STR.20.4.441 Bousser, 1983, “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia, Stroke, 14, 5, 10.1161/01.STR.14.1.5 Boysen, 1988, Danish very-low-dose aspirin after carotid endarterectomy trial, Stroke, 19, 1211, 10.1161/01.STR.19.10.1211 1978, A randomized trial of aspirin and sulfinpyra-zone in threatened stroke, N Engl J Med, 299, 53, 10.1056/NEJM197807132990201 Candelise, 1982, A randomized trial of aspirin and sulfinpyra-zone in patients with TIA, Stroke, 13, 175, 10.1161/01.STR.13.2.175 Eriksson, 1985, Enteric-coated acetylsalicylic acid plus dipyridamole compared with anticoagulants in the prevention of ischemic events with transient ischemic attacks, Acta Neurol Scand, 71, 485, 10.1111/j.1600-0404.1985.tb03232.x 1990, European Stroke Prevention Study, Stroke, 21, 1122, 10.1161/01.STR.21.8.1122 Evans, 1972, Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient ischemic attacks, Surgical Forum, 23, 239 Fields, 1977, Controlled trial of aspirin in cerebral ischemia, Stroke, 8, 301, 10.1161/01.STR.8.3.301 Fields, 1978, Controlled trial of aspirin in cerebral ischemia. Part II: Surgical group, Stroke, 9, 309, 10.1161/01.STR.9.4.309 Garde, 1983, Treatment after transient ischemic at tacks: A comparison between anticoagulant drug and inhibition of platelet aggregation, Stroke, 14, 677, 10.1161/01.STR.14.5.677 Gent, 1989, The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke, Lancet, 1, 1215, 10.1016/S0140-6736(89)92327-1 Harker, 1990, Antithrombotic therapy, 1569 Hass, 1989, A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients, N Engl J Med, 321, 501, 10.1056/NEJM198908243210804 Herskovits, 1985, Preventive treatment of cerebral tran sient ischemia. Comparative randomized trial of pentoxifylline versus conventional antiaggregants, Eur Neurol, 24, 73, 10.1159/000115765 Herskovits, 1981, Randomized trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischemic attacks, Lancet, 1, 966, 10.1016/S0140-6736(81)91732-3 Hirsh, 1989, Optimal therapeutic range for oral anticoagulants, Chest, 95, 5S Janzon, 1990, Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine: Results from STIMS, the Swedish Ticlopidine Multicenter Study, J Intern Med, 227, 301, 10.1111/j.1365-2796.1990.tb00164.x Jonas, 1988, Anticoagulant therapy in cerebrovascular disease: Review and meta-analyis, Stroke, 19, 1043, 10.1161/01.STR.19.8.1043 Kaplan, 1986 Kase, 1985, Anticoagulant-related intracerebral hemor rhage, Neurology, 35, 943, 10.1212/WNL.35.7.943 Keith, 1987, Heparin therapy for recent transient focal cerebral ischemia, Mayo Clin Proc, 62, 1101, 10.1016/S0025-6196(12)62503-8 Marquardsen, 1986, Epidemiology of strokes in Europe, 31 Poller, 1990, Prevention of stroke in atrial fibrillation [correspondence], N Engl J Med, 323, 483 Putman, 1985, Usefulness of heparin in the initial management of patients with recent transient ischemic attacks, Arch Neurol, 42, 960, 10.1001/archneur.1985.04060090042011 Roden, 1981, Transient cerebral ischaemic attacks—management and prognosis, Postgrad Med J, 57, 275, 10.1136/pgmj.57.667.275 Saltiel, 1987, Ticlopidine: A review of its pharmacodynamic and pharmacokietic properties, and therapeutic efficacy in platelet-dependent disease states, Drugs, 34, 222, 10.2165/00003495-198734020-00003 Sandok, 1978, Guidelines for the management of transient ischemic attacks, Mayo Clin Proc, 53, 665 Saour, 1990, Trial of different intensities of anticoagulation in patients with prosthetic heart valves, N Engl J Med, 322, 428, 10.1056/NEJM199002153220703 Smith, 1990, The effect of warfarin on mortality and reinfarction after myocardial infarction, N Engl J Med, 323, 147, 10.1056/NEJM199007193230302 Sorensen, 1983, Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks: A Danish cooperative study, Stroke, 14, 15, 10.1161/01.STR.14.1.15 Stallones RA, Dyken ML, Fang HCH, et al: Epidemiology for stroke facilities plan ning. Sahs AL, Hartman FC: Fundamentals of Stroke Care. Washington, US Department of Health, Education, and Welfare, Public Health Service, Health Resources Administration, 1976, pp 5-13 1990, Preliminary report of the Stroke Prevention Atrial Fibrillation Study, N Engl J Med, 322, 863, 10.1056/NEJM199003223221232 1987, High-dose acetylsalicyclic acid after cerebral infarction, Stroke, 18, 325, 10.1161/01.STR.18.2.325 1987, The European Stroke Prevention Study (ESPS): Principal end points, Lancet, 2, 1351 Uchiyama, 1989, Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia, Stroke, 20, 1643, 10.1161/01.STR.20.12.1643 1988, United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Interim results, Br Med J, 296, 316, 10.1136/bmj.296.6618.316 1961, An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease, Neurology, 11, 132 Whisnant, 1973, Transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969, Mayo Clin Proc, 48, 194 Wintzen, 1984, The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study, Ann Neurol, 16, 553, 10.1002/ana.410160505 Wolf, 1988, Cigarette smoking as a risk factor for stroke: The Framingham Study, JAMA, 259, 1025, 10.1001/jama.1988.03720070025028